Leah Kann
Leah Kann is a life science intern at ITIF and an honors student in Biology and Public Policy at the University of North Carolina, Chapel Hill.
Recent Publications
Driving American Innovation: Leveraging the Power of Women in STEM
As the United States seeks to boost domestic innovation and industry, unlocking the transformative potential of women in STEM is essential for to continue building American Innovation.
The Inflation Reduction Act Is Negotiating the United States Out of Drug Innovation
The Inflation Reduction Act (IRA) undermines innovation in small-molecule drugs by subjecting them to price controls after 9 years, whereas large-molecule drugs (biologics) are allowed 13 years of market pricing. Congress should pass the bipartisan EPIC Act to remedy this issue.
A Bipartisan Success: Celebrating 40 Years of the Hatch-Waxman Act
The 1984 Hatch-Waxman Act revolutionized the U.S. pharmaceutical industry, successfully balancing the interests of pharmaceutical innovation and affordability by creating legal pathways for accelerated generic drug competition while extending patent protections and introducing data exclusivities that preserved incentives for novel pharmaceutical innovation.